Skip to main content
Fig. 2 | Trials

Fig. 2

From: The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of OSteoporosis (PaVOS)- study protocol for a randomized controlled trial

Fig. 2

Timeline for participants. Figure 2 shows the timeline for the participants in the study. The x-axis is the time during the study in months. The participants will be randomized after baseline data is collected to an intervention group receiving whole-body vibration (WBV) in addition to PTH 1-34 compared to the control group receiving PTH 1-34 alone. After 12 months the intervention group will be re-randomized. BMD bone mineral density; HR-pQCT high-resolution peripheral quantitative computed tomography; Bone biomarkers procollagen type-1 amino-terminal propeptide (P1NP), carboxy-terminal type-1 collagen crosslinks (CTX), and sclerostin; Physical markers: Timed Up and Go (TUG), Short Physical Performance Battery (SPPB), grip strength and leg extensor power; DXA dual-energy x-ray absorptiometry; IPAQ The International Physical Activity Questionnaire; FES-I Falls Efficacy Scale International

Back to article page